US$ 21.70
glp-1 analog drugs Receptor Agonists: An Alternative for Rapid-Acting Insulin? GLP-1 Analogues in the Neurobiology
Description
All answers are self-reported and may underestimate prevalence of clinical conditions

For more information, visit www.wellgisticshealth.com

(2) in patients with a history of malignancy, particularly medullary thyroid carcinoma, the potential proliferative risks associated with GLP-1RAs must be weighed against their cardiovascular benefits

[DOI] [PubMed] 192.Khunti K., et al

doi:10.1155/2015/105828 44